BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Tamoxifen
,
rs7903146
,
TGFB1
,
Angiogenesis
,
Leukemia
,
Hippocampus
,
Nosology
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
lung squamous-cell carcinoma
Summary
General Info
Curated Studies
Most Correlated Studies
SBV IMPROVER Diagnostic Signature Challenge: lung adenocarcinomas and squamous cell cancers
Lung cancer primary tumors or xenografts from adenocarcinoma or squamous cell carcinoma patients
Lung squamous cell carcinoma (SCC) tissues, airway premalignant lesions and normal basal cells
Profiling of NSCLC patients for predicting recurrence free survival
Adenocarcinoma and squamous cell carcinoma in human Non-Small Cell Lung Cancer
Explore Curated Studies Results
Literature
Most Relevant Literature
Diagnostic Value of GDF10 for the Tumorigenesis and Immune Infiltration in Lung Squamous Cell Carcin…
c-Rel is a Novel Oncogene in Lung Squamous Cell Carcinoma Regulating Cell Proliferation and Migratio…
Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progr…
miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC.
Characterization and verification of CD81 as a potential target in lung squamous cell carcinoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamou…
Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma
Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcino…
Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ